MEDIDATA PLUS
An AI-Native foundation that powers all your trials.
Stitching together fragmented AI tools isn’t a strategy. It’s a liability that creates disjointed data, bloated timelines, and unpredictable costs. It’s time for a change.
Medidata Plus, powered by our AI orchestrator Dot, unlocks a single, platform-wide AI layer across your entire clinical lifecycle – turning data silos into connected intelligence.
AI adoption, simplified.
Actionable intelligence that takes you further.
Only 29% of life sciences leaders say AI meets or exceeds their expectations. The fact is, most AIs are point solutions, whereas Medidata Plus runs the whole trial. One AI layer delivers those capabilities across the Medidata Platform.
Dot Unlocked
Your AI virtual companion, agent, and trial orchestrator embedded throughout the Medidata Platform. It helps teams simulate outcomes, automate workflows, surface insights, and recommend next best actions.
Study builds accelerated
Go from weeks to hours. AI automates EDC and eCOA design and generates synthetic data for UAT.
No-Code Data Transformation
Seamlessly ingest, standardize, and transform data from clinical and real-world sources to extract insights without writing a single line of code.
Proactive De-Risking
Embedded analytics flag enrollment drops and safety signals early, cutting mid-cycle pauses.
Agentic Audit Exploration
Query your full audit history in plain language and get answers in minutes, not days.
Your AI virtual companion, agent, and trial orchestrator embedded throughout the Medidata Platform. It helps teams simulate outcomes, automate workflows, surface insights, and recommend next best actions.
“Applying Medidata AI across our global operations with a unified Medidata Platform strengthens how we support sponsors throughout the full clinical trial lifecycle.
It gives our teams better connectivity, clearer data, and the ability to make confident decisions faster. For our customers, that means less complexity, greater transparency, and a scalable foundation to support even the most complex clinical programs.”
Alistair Macdonald, CEO, Worldwide Clinical Trials
Industry Insights
FAQ
Explore Experiences
Discover the Medidata Platform